ClinicalTrials.Veeva

Menu

Combined Systemic Inflammatory Indices and Birth Weight

U

University of Campania "Luigi Vanvitelli"

Status

Completed

Conditions

Birth Weight
Systemic Inflammation Markers
Combined Systemic Inflammatory Indices

Treatments

Diagnostic Test: None intervention

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The study aimed to explore the complex relationship between various systemic inflammatory indices and birth weight

Full description

The research was structured as a prospective observational study. It was conducted at a second-level University Hospital over the period from December 2019 to February 2021.

Participants:

Blood samples were collected at hospital admission. These samples were used for a complete blood count, focusing specifically on deriving systemic inflammatory indices.

The primary inflammatory indices studied were Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Monocyte-to-Lymphocyte Ratio (MLR).

The birth weight was registered.

Enrollment

199 patients

Sex

Female

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • physiological Full-term pregnancies

Exclusion criteria

  • gestational diabetes
  • pregestational diabetes
  • Chronic Hypertension
  • Gestational Hypertension
  • Preeclampsia
  • Eclampsia
  • Intrauterine Fetal Growth Restriction
  • Preterm Delivery
  • Multiple Pregnancies
  • Fetal malformations

Trial design

199 participants in 1 patient group

full term pregnancy
Description:
Total Participants: The study included full-term pregnant women. Exclusion Criteria: Participants were carefully selected, excluding those with specific conditions that could confound the study results. These conditions included gestational and pregestational diabetes, chronic hypertension, gestational hypertension, pre-eclampsia/eclampsia, intrauterine fetal growth restriction, preterm delivery, multiple pregnancies, and prenatally detected fetal abnormalities.
Treatment:
Diagnostic Test: None intervention

Trial contacts and locations

1

Loading...

Central trial contact

Marco La Verde, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems